Linda Bain

Linda Bain discloses dealings in 4 companies, chiefly bluebird bio, Inc., Adverum Biotechnologies, Inc. and Codiak BioSciences, Inc. We count 37 filings; the first trade dates from 16 December 2013 and the latest from 24 June 2026.

The open-market record consists of 16 sales worth €514k, with no purchase. The rest of the record consists of 6 share grants and 15 option exercises.

Most recently, on 26 June 2026, the filings show a share grant in Arvinas, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.